128 related articles for article (PubMed ID: 9869271)
1. Profile of JTE-522 as a human cyclooxygenase-2 inhibitor.
Wakitani K; Nanayama T; Masaki M; Matsushita M
Jpn J Pharmacol; 1998 Nov; 78(3):365-71. PubMed ID: 9869271
[TBL] [Abstract][Full Text] [Related]
2. Biochemical and pharmacological profile of a tetrasubstituted furanone as a highly selective COX-2 inhibitor.
Riendeau D; Percival MD; Boyce S; Brideau C; Charleson S; Cromlish W; Ethier D; Evans J; Falgueyret JP; Ford-Hutchinson AW; Gordon R; Greig G; Gresser M; Guay J; Kargman S; Léger S; Mancini JA; O'Neill G; Ouellet M; Rodger IW; Thérien M; Wang Z; Webb JK; Wong E; Chan CC
Br J Pharmacol; 1997 May; 121(1):105-17. PubMed ID: 9146894
[TBL] [Abstract][Full Text] [Related]
3. Effects of JTE-522, a specific inhibitor of cyclooxygenase-2, on the recurrence of allergic inflammation in rats.
Niki H; Yamada M; Yamaki K; Mue S; Ohuchi K
Eur J Pharmacol; 1998 Mar; 344(2-3):261-7. PubMed ID: 9600662
[TBL] [Abstract][Full Text] [Related]
4. Pharmacological profile of JTE-522, a novel prostaglandin H synthase-2 inhibitor, in rats.
Matsushita M; Masaki M; Yagi Y; Tanaka T; Wakitani K
Inflamm Res; 1997 Nov; 46(11):461-6. PubMed ID: 9427067
[TBL] [Abstract][Full Text] [Related]
5. JTE-522 selectively inhibits cyclooxygenase-2-derived prostaglandin production in inflammatory tissues.
Wakitani K; Tazaki H; Matsushita M; Iwamura H
Inflamm Res; 2000 Mar; 49(3):117-22. PubMed ID: 10807499
[TBL] [Abstract][Full Text] [Related]
6. Suppression of N-nitrosomethylbenzylamine (NMBA)-induced esophageal tumorigenesis in F344 rats by JTE-522, a selective COX-2 inhibitor.
Li Z; Shimada Y; Kawabe A; Sato F; Maeda M; Komoto I; Hong T; Ding Y; Kaganoi J; Imamura M
Carcinogenesis; 2001 Apr; 22(4):547-51. PubMed ID: 11285187
[TBL] [Abstract][Full Text] [Related]
7. 4-(4-cycloalkyl/aryl-oxazol-5-yl)benzenesulfonamides as selective cyclooxygenase-2 inhibitors: enhancement of the selectivity by introduction of a fluorine atom and identification of a potent, highly selective, and orally active COX-2 inhibitor JTE-522(1).
Hashimoto H; Imamura K; Haruta J; Wakitani K
J Med Chem; 2002 Mar; 45(7):1511-7. PubMed ID: 11906292
[TBL] [Abstract][Full Text] [Related]
8. The potential for a selective cyclooxygenase-2 inhibitor in the prevention of liver metastasis in human colorectal cancer.
Yamauchi T; Watanabe M; Hasegawa H; Nishibori H; Ishii Y; Tatematsu H; Yamamoto K; Kubota T; Kitajima M
Anticancer Res; 2003; 23(1A):245-9. PubMed ID: 12680220
[TBL] [Abstract][Full Text] [Related]
9. Synergistic cytotoxicity and apoptosis of JTE-522, a selective cyclooxygenase-2 inhibitor, and 5-fluorouracil against bladder cancer.
Mizutani Y; Kamoi K; Ukimura O; Kawauchi A; Miki T
J Urol; 2002 Dec; 168(6):2650-4. PubMed ID: 12442003
[TBL] [Abstract][Full Text] [Related]
10. Comparison of the cyclooxygenase-1 inhibitory properties of nonsteroidal anti-inflammatory drugs (NSAIDs) and selective COX-2 inhibitors, using sensitive microsomal and platelet assays.
Riendeau D; Charleson S; Cromlish W; Mancini JA; Wong E; Guay J
Can J Physiol Pharmacol; 1997 Sep; 75(9):1088-95. PubMed ID: 9365818
[TBL] [Abstract][Full Text] [Related]
11. Induction of apoptosis by JTE-522, a specific cyclooxygenase-2 inhibitor, in human gastric cancer cell lines.
Uefuji K; Ichikura T; Shinomiya N; Mochizuki H
Anticancer Res; 2000; 20(6B):4279-84. PubMed ID: 11205258
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of haematogenous metastasis of colon cancer in mice by a selective COX-2 inhibitor, JTE-522.
Tomozawa S; Nagawa H; Tsuno N; Hatano K; Osada T; Kitayama J; Sunami E; Nita ME; Ishihara S; Yano H; Tsuruo T; Shibata Y; Muto T
Br J Cancer; 1999 Dec; 81(8):1274-9. PubMed ID: 10604722
[TBL] [Abstract][Full Text] [Related]
13. Inhibitory effect of a selective cyclooxygenase-2 inhibitor on liver metastasis of colon cancer.
Nagatsuka I; Yamada N; Shimizu S; Ohira M; Nishino H; Seki S; Hirakawa K
Int J Cancer; 2002 Aug; 100(5):515-9. PubMed ID: 12124799
[TBL] [Abstract][Full Text] [Related]
14. Prostacyclin synthase gene transfer modulates cyclooxygenase-2-derived prostanoid synthesis and inhibits neointimal formation in rat balloon-injured arteries.
Yamada M; Numaguchi Y; Okumura K; Harada M; Naruse K; Matsui H; Ito T; Hayakawa T
Arterioscler Thromb Vasc Biol; 2002 Feb; 22(2):256-62. PubMed ID: 11834525
[TBL] [Abstract][Full Text] [Related]
15. Mechanisms of anti-proliferative effect of JTE-522, a selective cyclooxygenase-2 inhibitor, on human liver cancer cells.
Nagahara T; Okano J; Murawaki Y
Oncol Rep; 2007 Nov; 18(5):1281-90. PubMed ID: 17914586
[TBL] [Abstract][Full Text] [Related]
16. A selective cyclooxygenase-2 inhibitor suppresses tumor growth in nude mouse xenografted with human head and neck squamous carcinoma cells.
Nishimura G; Yanoma S; Mizuno H; Kawakami K; Tsukuda M
Jpn J Cancer Res; 1999 Oct; 90(10):1152-62. PubMed ID: 10595745
[TBL] [Abstract][Full Text] [Related]
17. Cyclooxygenase-2 downregulates inducible nitric oxide synthase in rat intestinal epithelial cells.
Kobayashi O; Miwa H; Watanabe S; Tsujii M; Dubois RN; Sato N
Am J Physiol Gastrointest Liver Physiol; 2001 Sep; 281(3):G688-96. PubMed ID: 11518681
[TBL] [Abstract][Full Text] [Related]
18. 4,5-Diaryloxazole inhibitors of cyclooxygenase-2 (COX-2).
Talley JJ; Bertenshaw SR; Brown DL; Carter JS; Graneto MJ; Koboldt CM; Masferrer JL; Norman BH; Rogier DJ; Zwwifel BS; Seibert K
Med Res Rev; 1999 May; 19(3):199-208. PubMed ID: 10232649
[TBL] [Abstract][Full Text] [Related]
19. JTE-522, a selective COX-2 inhibitor, inhibits cell proliferation and induces apoptosis in RL95-2 cells.
Li HL; Zhang HW; Chen DD; Zhong L; Ren XD; St-Tu R
Acta Pharmacol Sin; 2002 Jul; 23(7):631-7. PubMed ID: 12100758
[TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetics and safety of JTE-522, a novel selective cyclooxygenase-2 inhibitor, in healthy male volunteers.
Ikeda Y; Umemura K; Kondo K; Nakashima M; Kobayashi T; Takahashi M
Br J Clin Pharmacol; 2002 Nov; 54(5):453-62. PubMed ID: 12445023
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
